Valenzuela, Raul F.
Duran-Sierra, Elvis
Antony, Mathew
Amini, Behrang
Lo, Sam
Torres, Keila. E.
Hwang, Ken-Pin
Ma, Jingfei
Stafford, R. Jasson
Ratan, Ravin
Madewell, John E.
Araujo, Dejka
Murphy, William A. Jr.
Costelloe, Colleen M.
Funding for this research was provided by:
The John S. Dunn, Sr. Distinguished Chair in Diagnostic Imaging
M.R. Evelyn Hudson Foundation Endowed Professorship
Article History
Received: 28 January 2025
Accepted: 3 June 2025
First Online: 1 July 2025
Declarations
:
: The authors declare no competing interests.
: Our study does not include animal or human experimentation and is not part of a clinical trial. All included authors have contributed to the current article. All data collection, management, and processing methods were performed by the relevant guidelines and regulations, including institutional and generally accepted clinical, research, and ethical guidelines and regulations, as well as those related to the protection of data veracity and personal health information (PHI).
: Due to the study’s retrospective nature, our Institutional Review Board waived the need to obtain informed consent and gave ethical and administrative approval to our research under the IRB identifier PA16-0857 Protocol Name: “Utility of imaging of bone and soft tissue tumors and disease and treatment-related changes for diagnosis, prognosis, treatment response, and outcome.”